MicroBeaCh (Microfluidic Platform for Analyzing Sperm Flagellar Beating in a Chemical Gradient) studies the fourth natural cue behind EVA: chemotaxis.
Fertilisation has long been pictured as a race won by the fastest swimmer. Research over the last decade tells a more active story: the egg itself takes part, releasing chemical signals that help guide sperm toward it1. As sperm travel through the female reproductive tract, rheotaxis and thermotaxis already help steer their path2; along the way they undergo capacitation, a sequence of biochemical changes that prepares them for fertilisation3.
Capacitation brings a shift in how the tail beats, from a symmetrical stroke to an asymmetrical one known as hyperactivation, letting a sperm cell force its way through the cumulus-oocyte complex surrounding the egg4. The fluid around the egg is rich in signalling molecules (progesterone, EGF, BDNF, GDF9, fibronectin, and others) thought to shape this final approach5. But exactly how the flagellum adapts, beat by beat, to that chemical landscape is still poorly understood: existing methods typically test only a narrow set of these signals, and rarely under conditions that resemble the real tract.
A biomimetic microfluidic platform, paired with AI-powered vision, aimed at a single question: how does the flagellum actually respond to the chemical signals it meets near the egg?
A microfluidic platform reproduces the physiological chemical environment sperm meet in the female reproductive tract.
Computer vision tracks flagellar motion in real time, turning each beat into precise, automated motility data.
The aim: identify motility parameters that reflect true fertilising capability, deepening the intelligence behind EVA's selection.
MicroBeaCh is the first study to comprehensively assess sperm flagellar beating across a dynamic chemical landscape, rather than a single fixed stimulus. Three things make that possible:
Beezbiotech is the sole host organisation for this fellowship. Results will be shared through scientific publications and conference presentations, alongside dedicated outreach to engage the wider community in fertility science.
This project has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement No. 101154015.